Standigm Secures $44.5 M in Pre-IPO Funding Round

06 Mar, 2021

Standigm Secures $44.5 M in Pre-IPO Funding Round
Photo by Tierra Mallorca on Unsplash

– Standigm closed a $44.5m pre-IPO funding round co-led by SKS PE and Daishin Private Equity.
– The round was joined by new investors in banking and technology, including SKS PE, Daishin Private Equity, InterVest, KDB Bank, and Asset One.
– Standigm’s second-largest shareholder, SK holdings, also participated through acquiring existing shares.
– The closing marks the last round of funding before Standigm goes to its planned initial public offering (IPO) on the Korea Exchange (KRX) later this year.
– Founded in 2015, Standigm has achieved full-stack AI-driven industrializing drug discovery.
– Standigm’s AI platforms range from new drug target discovery to novel drug lead generation, enabling pharmaceutical companies to save time and cost.

Artificial Intelligence Asia Biotechnology Health Care Machine Learning Pharmaceutical
Crunchbase icon

Content report

The following text will be sent to our editors: